1. TMEM63C, a Potential Novel Target for Albuminuria Development, Is Regulated by MicroRNA-564 and Transforming Growth Factor beta in Human Renal Cells
   Miriam Orphal et al, 2020, Kidney and Blood Pressure Research CrossRef
2. Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins
   Soudeh Ghafouri-Fard et al, 2022, Frontiers in Oncology CrossRef
3. Urinary MicroRNA-21-5p as Potential Biomarker of Interstitial Fibrosis and Tubular Atrophy (IFTA) in Kidney Transplant Recipients
   Michal S. Gniewkiewicz et al, 2020, Diagnostics CrossRef
4. Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization
   Quentin Roblain et al, 2021, Aging CrossRef
5. Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
   Gabriel Rinnerthaler et al, 2020, Journal of Clinical Medicine CrossRef
6. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
   Jonathan Xu et al, 2022, Urologic Cancers CrossRef
7. Kidney Cancer and Chronic Kidney Disease: Too Close for Comfort
   Pedro Caetano Pinto et al, 2021, Biomedicines CrossRef
8. LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma
   José Pedro Sequeira et al, 2022, Cancers CrossRef
9. Footprints of microRNAs in Cancer Biology
   Yaashini Rajasegaran et al, 2021, Biomedicines CrossRef
10. WWP2 ameliorates oxidative stress and inflammation in atherosclerotic mice through regulation of PDCD4/HO-1 pathway
    Xingye Wang et al, 2022, Acta Biochimica et Biophysica Sinica CrossRef
11. MiRNAs in renal cell carcinoma
    Jesús Miranda-Poma et al, 2022, Clinical and Translational Oncology CrossRef
12. Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies
    Anchal Pathak et al, 2024, Stem Cells International CrossRef